Search research articles
Contact Us
Filters
Showing results (51-60 of 178) with videos related to
Page
of 18
Sort By:
Expert Opinion on Drug Delivery
|
November 22, 2005
Advances in the delivery of treatments for Parkinson's disease
Tom H Johnston, Susan H Fox, Jonathan M Brotchie
The Lancet. Neurology
|
October 14, 2008
Non-dopaminergic treatments in development for Parkinson's disease
Susan H Fox, Jonathan M Brotchie, Anthony E Lang
Movement Disorders Clinical Practice
|
October 27, 2018
Clozapine in Parkinsonian Rest Tremor: A Review of Outcomes, Adverse Reactions, and Possible Mechanisms of Action
Tay Kay Yaw, Susan H Fox, Anthony E Lang
Movement Disorders : Official Journal of the Movement Disorder Society
|
December 11, 2012
Novel nondopaminergic targets for motor features of Parkinson's disease: review of recent trials
Lorraine V Kalia, Jonathan M Brotchie, Susan H Fox
Seminars in Neurology
|
May 17, 2017
Motor Complications of Dopaminergic Medications in Parkinson's Disease
Maria Eliza Freitas, Christopher W Hess, Susan H Fox
Archives of Neurology
|
February 11, 2009
Overview of the extranigral aspects of Parkinson disease
Shen-Yang Lim, Susan H Fox, Anthony E Lang
Movement Disorders : Official Journal of the Movement Disorder Society
|
December 16, 2003
Pure cerebello-olivary degeneration of Marie, Foix, and Alajouanine presenting with progressive cerebellar ataxia, cognitive decline, and chorea
Susan H Fox, Anette Nieves, Catherine Bergeron, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
January 25, 2011
Mitochondrial mimicry of multiple system atrophy of the cerebellar subtype
Arpan R Mehta, Susan H Fox, Mark Tarnopolsky, et al.
Parkinsonism & Related Disorders
|
May 12, 2018
Automated assessment of levodopa-induced dyskinesia: Evaluating the responsiveness of video-based features
Michael H Li, Tiago A Mestre, Susan H Fox, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
December 5, 2002
Stimulation of cannabinoid receptors reduces levodopa-induced dyskinesia in the MPTP-lesioned nonhuman primate model of Parkinson's disease
Susan H Fox, Brian Henry, Michael Hill, et al.
Page
of 18
Search research articles
Search
Showing results (51-60 of 178) with videos related to
Sort By:
Page
of 18
Expert Opinion on Drug Delivery
|
November 22, 2005
Advances in the delivery of treatments for Parkinson's disease
Tom H Johnston, Susan H Fox, Jonathan M Brotchie
The Lancet. Neurology
|
October 14, 2008
Non-dopaminergic treatments in development for Parkinson's disease
Susan H Fox, Jonathan M Brotchie, Anthony E Lang
Movement Disorders Clinical Practice
|
October 27, 2018
Clozapine in Parkinsonian Rest Tremor: A Review of Outcomes, Adverse Reactions, and Possible Mechanisms of Action
Tay Kay Yaw, Susan H Fox, Anthony E Lang
Movement Disorders : Official Journal of the Movement Disorder Society
|
December 11, 2012
Novel nondopaminergic targets for motor features of Parkinson's disease: review of recent trials
Lorraine V Kalia, Jonathan M Brotchie, Susan H Fox
Seminars in Neurology
|
May 17, 2017
Motor Complications of Dopaminergic Medications in Parkinson's Disease
Maria Eliza Freitas, Christopher W Hess, Susan H Fox
Archives of Neurology
|
February 11, 2009
Overview of the extranigral aspects of Parkinson disease
Shen-Yang Lim, Susan H Fox, Anthony E Lang
Movement Disorders : Official Journal of the Movement Disorder Society
|
December 16, 2003
Pure cerebello-olivary degeneration of Marie, Foix, and Alajouanine presenting with progressive cerebellar ataxia, cognitive decline, and chorea
Susan H Fox, Anette Nieves, Catherine Bergeron, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
January 25, 2011
Mitochondrial mimicry of multiple system atrophy of the cerebellar subtype
Arpan R Mehta, Susan H Fox, Mark Tarnopolsky, et al.
Parkinsonism & Related Disorders
|
May 12, 2018
Automated assessment of levodopa-induced dyskinesia: Evaluating the responsiveness of video-based features
Michael H Li, Tiago A Mestre, Susan H Fox, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
December 5, 2002
Stimulation of cannabinoid receptors reduces levodopa-induced dyskinesia in the MPTP-lesioned nonhuman primate model of Parkinson's disease
Susan H Fox, Brian Henry, Michael Hill, et al.
Page
of 18